Avalon Investment & Advisory’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$265K Sell
1,037
-1,593
-61% -$392K 0.01% 288
2022
Q4
$698K Sell
2,630
-496
-16% -$121K 0.02% 228
2022
Q3
$586K Sell
3,126
-512
-14% -$110K 0.02% 223
2022
Q2
$730K Sell
3,638
-2,248
-38% -$527K 0.02% 215
2022
Q1
$1.78M Buy
5,886
+2,005
+52% +$586K 0.04% 175
2021
Q4
$1.39M Sell
3,881
-2,188
-36% -$753K 0.03% 191
2021
Q3
$2.01M Buy
6,069
+342
+6% +$115K 0.05% 196
2021
Q2
$1.76M Buy
5,727
+231
+4% +$64.8K 0.04% 203
2021
Q1
$1.35M Buy
5,496
+879
+19% +$221K 0.03% 216
2020
Q4
$1.26M Buy
4,617
+954
+26% +$237K 0.03% 232
2020
Q3
$866K Buy
3,663
+585
+19% +$131K 0.02% 227
2020
Q2
$585K Buy
+3,078
New +$552K 0.01% 234

Other funds holding ISRG

Avalon Investment & Advisory's ISRG Position: Q1 2023 in Review

Avalon Investment & Advisory reduced its Intuitive Surgical (ISRG) stake by 61% in Q1 2023, selling an estimated $392K and leaving 1,037 shares worth $265K. The position accounts for 0.01% of the portfolio, ranked #288.

Avalon Investment & Advisory first reported a position in ISRG in Q2 2020 and has held it in 12 quarters since. The position peaked at $2.01M in Q3 2021. 1,411 funds tracked by Wall St. Rank hold ISRG as of Q1 2023.

  • Avalon Investment & Advisory held 1,037 shares of Intuitive Surgical worth $265K as of Q1 2023.
  • Avalon Investment & Advisory sold 1,593 Intuitive Surgical shares in Q1 2023, an estimated $392K.
  • Intuitive Surgical made up 0.01% of Avalon Investment & Advisory's portfolio in Q1 2023, its #288 holding.
  • Avalon Investment & Advisory first reported a position in Intuitive Surgical in Q2 2020 and has held it in 12 quarters since.
  • Avalon Investment & Advisory's Intuitive Surgical position peaked at $2.01M in Q3 2021.
  • 1,411 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2023.

Based on Avalon Investment & Advisory's 13F filing for Q1 2023, filed 15 May 2023.